Digital Health Acquisition Corp. is a special purpose acquisition company (SPAC) formed to identify, acquire and merge with one or more businesses in the digital health, healthcare IT and life sciences technology sectors. Founded in 2021, the company raised capital through an initial public offering on the Nasdaq under the ticker DHAC. As a blank-check vehicle, Digital Health Acquisition seeks to leverage public markets to provide private companies in its target industries with growth capital and scale.
The company does not operate commercial products or services of its own, but rather sponsors a trust fund of cash proceeds that will be used to complete a business combination. It is focused on opportunities in telemedicine, remote monitoring, digital therapeutics, data analytics and other technology-driven healthcare solutions. Subject to shareholder approval, Digital Health Acquisition aims to partner with businesses that have established customer bases, recurring revenue models and opportunities for global expansion.
While Digital Health Acquisition’s corporate headquarters are located in New York City, its search for a merger candidate is not geographically limited. The management team includes executives and advisors with experience in healthcare investing, medical device commercialization and digital health strategy, and they intend to target companies in North America, Europe and select Asian markets where digital adoption in healthcare is accelerating.
Under SEC rules governing SPACs, Digital Health Acquisition has up to two years from its IPO date to complete an initial business combination. If no merger is consummated within the specified timeframe, the company must return the trust proceeds to public shareholders. By focusing on the rapidly evolving digital health ecosystem, DHAC aims to create value through partnerships with innovative, scalable businesses at the forefront of healthcare transformation.
AI Generated. May Contain Errors.
